In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report). The company’s shares closed yesterday at $20.87. Easily identify ...

Aurobindo Pharma Ltd's wholly owned subsidiary, Helix Healthcare B.V, Netherlands, has on August 29, 2019 entered into an agreement with Shanghai LongJin Investment Company Ltd., China and Sveva ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

Investing.com-- Sun Pharmaceutical (TADAWUL:2070) Industries Ltd. (NSE:SUN) said on Monday that it will buy Checkpoint Therapeutics Inc (NASDAQ:CKPT)- a Nasdaq-listed immunotherapy and oncology ...

Shares in digital and delivery firms led gains during the pandemic, alongside those of vaccine-making pharmaceutical companies. Five years on, some pandemic-era gainers have lost most of their ...

As a result, you cannot buy them over the counter (OTC) — they require a consultation with a doctor. *Source: National Institutes of Health: NIDDK (2017). If you’re comfortable talking about ...

They outlast both presidents and their whims. Let's start with an example. Whether the Nifty is at 26,000 or 22,000, does it matter to the bottom line of a pharma company which recently received US ...

who also intended to buy 15 lakh shares, valued at Tk 32 crore at the market price at that time. As of November 30 last year, Tapan Chowdhury held a 9.47 percent stake in Square Pharmaceuticals, a ...

According to the disclosure, Tapan will buy the shares at the prevailing market price. Keep updated, follow The Business Standard's Google news channel Square Pharma's share price closed at Tk216.90 ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) today. The company’s shares closed yesterday at $33.01. See what stocks are receiving ...